| Product NDC: | 63304-099 |
| Proprietary Name: | Sumatriptan |
| Non Proprietary Name: | Sumatriptan |
| Active Ingredient(s): | 100 mg/1 & nbsp; Sumatriptan |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63304-099 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076572 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090210 |
| Package NDC: | 63304-099-13 |
| Package Description: | 120 TABLET in 1 BOTTLE (63304-099-13) |
| NDC Code | 63304-099-13 |
| Proprietary Name | Sumatriptan |
| Package Description | 120 TABLET in 1 BOTTLE (63304-099-13) |
| Product NDC | 63304-099 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sumatriptan |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090210 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | SUMATRIPTAN SUCCINATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |